Mirabegron

Spezifikationen

223673-61-8CAS-Nummer

800-126-3EG-Nummer

2-(2-amino-1,3-thiazol-4-yl)-N-[4-[2-[[(2R)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]acetamideIUPAC-Name

C21H24N4O2SChemische Formel

396.5 g/molMolekulargewicht

Mirabegron; 223673-61-8; Myrbetriq; Betanis; Betmiga; YM-178; YM178; MVR3JL3B2V; 2-(2-amino-1,3-thiazol-4-yl)-N-[4-(2-{[(2R)-2-hydroxy-2-phenylethyl]amino}ethyl)phenyl]acetamide; CHEBI:65349; DTXSID101021648; 2-(2-amino-1,3-thiazol-4-yl)-N-[4-[2-[[(2R)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]acetamide; 2-(2-Aminothiazol-4-yl)-4'-(2-((2-hydroxy-2-phenylethyl)amino)ethyl)acetanilide; 4-Thiazoleacetamide, 2-amino-N-(4-(2-(((2R)-2-hydroxy-2-phenylethyl)amino)ethyl)phenyl)-; 2-(2-AMINO-1,3-THIAZOL-4-YL)-N-(4-(2-(((2R)-2-HYDROXY-2-PHENYLETHYL)AMINO)ETHYL)PHENYL)ACETAMIDE; mirabegronum; RefChem:58592; MYRBETRIQ GRANULES; G04BD12; DTXCID401506657; 2-(2-Aminothiazol-4-yl)-N-(4-(2-(((2R)-2-hydroxy-2-phenylethyl)amino)ethyl)phenyl) Acetamide; 2-Amino-N-[4-[2-[[(2R)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-4-thiazoleacetamide; YM 178; Mirabegron (YM178); MFCD11100356; (R)-2-(2-aminothiazol-4-yl)-N-(4-(2-((2-hydroxy-2-phenylethyl)amino)ethyl)phenyl)acetamide; C21H24N4O2S; (R)-2-(2-aminothiazol-4-yl)-N-(4-(2-(2-hydroxy-2-phenylethylamino)ethyl)phenyl)acetamide; Myrbetriq (TN); 2-(2-azanyl-1,3-thiazol-4-yl)-N-[4-[2-[[(2R)-2-oxidanyl-2-phenyl-ethyl]amino]ethyl]phenyl]ethanamide; Mirabegron [USAN:INN]; UNII-MVR3JL3B2V; Mirabegron CRS; Mirabegron (Standard); Mirabegron racemate CRS; MIRABEGRON [MI]; MIRABEGRON [INN]; MIRABEGRON [JAN]; MIRABEGRON [USAN]; Mirabegron [EP monograph]; MIRABEGRON [VANDF]; MIRABEGRON [MART.]; MIRABEGRON [WHO-DD]; Mirabegron (JAN/USAN/INN); SCHEMBL904788; GTPL7445; orb1225615; orb1307816; CHEMBL2095212; MIRABEGRON [ORANGE BOOK]; GLXC-10840; HMS3714I09; HMS3885M16; EX-A1050; EBC-26934; HY-14773R; MSK158016; AKOS016340341; CCG-268611; CS-0915; DB08893; FM26011; KS-1398; NCGC00386239-01; NCGC00386239-02; NCGC00386239-05; NCGC00386239-08; 2-(2-aminothiazol-4-yl)-N-[4-[2-[[(2R)-2-hydroxy-2-phenyl-ethyl]amino]ethyl]phenyl]acetamide; HY-14773; SY046867; NS00099356; SW220301-1; D09535; AB01565808_02; AR-270/43507997; Q3702534; BRD-K47949423-001-02-3; BRD-K47949423-001-03-1; Z1980444597; (R)-2-(2-aminothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetanilide; (2R)-2-(2-Aminothiazol-4-yl)-4'-[2-[(2-hydrox y-2-phenylethyl)amino]ethyl]acetic acid anilide; (R)-2-(2-Amino-4-thiazolyl)-N-[4-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]phenyl]acetamide; 2-(2-AMINO-1,3-THIAZOL-4-YL)-N-(4-{2-[(2-HYDROXY-2-PHENYLETHYL)AMINO]ETHYL}PHENYL)ACETAMIDE; 2-(2-Aminothiazol-4-yl)-N-[4-(2-{[(2R)-2-hydroxy-2-phenylethyl]amino}ethyl)phenyl]acetamide; H6U; Mirabegron HydrateSynonyme